SFM
Spartan Fund Management’s Teva Pharmaceuticals TEVA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $3.27M | Hold |
148,300
| – | – | 10.91% | 1 |
|
|
2024
Q3 | $2.67M | Hold |
148,300
| – | – | 8.06% | 1 |
|
|
2024
Q2 | $2.41M | Buy |
148,300
+200
| +0.1% | +$3.25K | 6.77% | 1 |
|
|
2024
Q1 | $2.09M | Buy |
148,100
+4,900
| +3% | +$69.1K | 4.27% | 5 |
|
|
2023
Q4 | $1.5M | Hold |
143,200
| – | – | 1.84% | 20 |
|
|
2023
Q3 | $1.46M | Sell |
143,200
-1,077
| -0.7% | -$11K | 1.1% | 41 |
|
|
2023
Q2 | $2.16M | Buy |
144,277
+2,477
| +2% | +$37K | 0.52% | 68 |
|
|
2023
Q1 | $1.25M | Buy |
141,800
+6,200
| +5% | +$54.9K | 0.58% | 60 |
|
|
2022
Q4 | $1.27M | Buy |
135,600
+15,500
| +13% | +$145K | 0.46% | 78 |
|
|
2022
Q3 | $968K | Buy |
120,100
+8,600
| +8% | +$69.3K | 0.29% | 157 |
|
|
2022
Q2 | $838K | Buy |
+111,500
| New | +$838K | 0.18% | 224 |
|